Global Aortic Aneurysm Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA).By Product;
Stent Grafts, Catheters and Others.By Treatment;
Endovascular Aneurysm Repair (EVAR) and Open Surgical Repair (OSR).By End User;
Hospitals And Clinics, Ambulatory Surgery Centers (ASCs) and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Aortic Aneurysm Market (USD Million), 2021 - 2031
In the year 2024, the Global Aortic Aneurysm Market was valued at USD 2,690.64 million. The size of this market is expected to increase to USD 4,671.40 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.2%.
Certainly! Here's an introduction structured into four paragraphs for the global aortic aneurysm market:
Aortic aneurysm, a condition characterized by the weakening and ballooning of the aorta—the body’s main artery—is a critical medical concern globally. The prevalence of aortic aneurysms has been steadily rising, driven primarily by aging populations and lifestyle factors such as smoking and hypertension. This increase has spurred significant interest and investment in the development of effective diagnostic tools and treatment options, driving the growth of the global aortic aneurysm market.
The market landscape for aortic aneurysm encompasses a range of diagnostic modalities and treatment approaches tailored to the diverse needs of patients. Diagnostic techniques include imaging studies such as ultrasound, CT scans, and MRI, which enable healthcare providers to accurately assess the size and location of aneurysms. Early detection plays a crucial role in managing aortic aneurysms effectively, as timely intervention can help prevent life-threatening complications such as rupture.
In terms of treatment, surgical interventions and minimally invasive procedures are at the forefront of medical advancements. Traditional open surgery for aortic aneurysm repair has gradually given way to endovascular repair (EVAR), a less invasive procedure that involves inserting a stent graft to reinforce the weakened artery wall. EVAR has gained popularity due to its reduced recovery times and lower procedural risks compared to open surgery, thereby driving its adoption and contributing to the expansion of the market.
The global aortic aneurysm market is also shaped by ongoing research and development efforts aimed at improving treatment outcomes and patient care. Innovations in biomaterials for stent grafts, advancements in imaging technology for better visualization of aneurysms, and personalized medicine approaches are key areas of focus. Moreover, collaborations between healthcare providers, research institutions, and pharmaceutical companies are pivotal in accelerating the pace of innovation and expanding the therapeutic options available to patients worldwide. As the understanding of aortic aneurysms continues to evolve, so too does the landscape of the market, promising continued growth and improved outcomes for patients in the years to come.
Global Aortic Aneurysm Market Recent Developments
- In January 2022, Cardiovascular Systems, Inc. along with OrbusNeich Medical Company Ltd (OrbusNeich), received approval from the United States Food and Drug Administration for OrbusNeich's Scoreflex NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter (Scoreflex NC).
- In January 2022, Humacyte reported preclinical results of a Small-Diameter Human Acellular Vessel (HAV) in Coronary Artery Bypass Grafting.
Segment Analysis
This report extensively covers different segments of Global Aortic Aneurysm Market and provides an in depth analysis segmented by Type, Product, Treatment, End User and Geography.
The global aortic aneurysm market is segmented by type into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA), reflecting distinct anatomical locations and varying treatment approaches tailored to each condition's characteristics and risks. This segmentation allows healthcare providers to customize diagnostic and therapeutic strategies based on the specific needs and anatomical considerations of patients with either AAA or TAA.
The global aortic aneurysm market is segmented by product into stent grafts, catheters, and other medical devices. Stent grafts are commonly used for endovascular repair (EVAR), offering minimally invasive treatment options for both abdominal and thoracic aortic aneurysms.
The global aortic aneurysm market is segmented by treatment into Endovascular Aneurysm Repair (EVAR), which involves minimally invasive insertion of a stent graft, and Open Surgical Repair (OSR), which entails traditional open surgery to repair the weakened section of the aorta. EVAR has gained popularity due to its lower procedural risks and faster recovery times compared to OSR, driving its adoption in clinical practice globally.
The global aortic aneurysm market is segmented by end users into hospitals and clinics, ambulatory surgery centers (ASCs), and other healthcare facilities. Hospitals and clinics dominate this segment due to their comprehensive capabilities in managing both elective and emergency cases of aortic aneurysms, while ASCs cater to the increasing demand for outpatient procedures, offering convenience and cost-effectiveness for certain treatments.
The global aortic aneurysm market is segmented by geography into major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each region exhibits unique healthcare infrastructures, prevalence rates, and regulatory environments influencing market dynamics and treatment trends for aortic aneurysms.
Global Aortic Aneurysm Segment Analysis
In this report, the Global Aortic Aneurysm Market has been segmented by Type, Product, Treatment, End User and Geography.
Global Aortic Aneurysm Market, Segmentation by Type
The Global Aortic Aneurysm Market has been segmented by Type into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA).
The global aortic aneurysm market is segmented primarily into two main types: abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). Abdominal aortic aneurysms occur below the diaphragm in the abdominal area of the aorta, while thoracic aortic aneurysms occur in the chest region above the diaphragm. These distinctions are crucial as they affect the treatment approach and clinical management strategies due to differences in anatomical location and associated risks.
Abdominal aortic aneurysms (AAA) are more common than thoracic aortic aneurysms (TAA), accounting for a significant majority of cases globally. The prevalence of AAA increases with age and is more frequently observed in males than females. Screening programs often target populations at higher risk, such as older adults with a history of smoking or hypertension, to detect AAA early and initiate appropriate interventions to prevent rupture, which can be life-threatening.
In contrast, thoracic aortic aneurysms (TAA) are less common but pose unique challenges due to their proximity to vital organs and the heart. They are often associated with genetic conditions such as Marfan syndrome and familial thoracic aortic aneurysm and dissection (FTAAD). Management of TAA requires careful monitoring and may involve surgical intervention to prevent complications such as aortic dissection or rupture, which carry high mortality rates.
Segmentation of the global aortic aneurysm market by type allows healthcare providers and researchers to tailor treatment approaches and innovations specific to the anatomical location and clinical characteristics of AAA and TAA. This targeted approach aims to improve patient outcomes, reduce morbidity and mortality associated with aortic aneurysms, and optimize healthcare resource allocation on a global scale.
Global Aortic Aneurysm Market, Segmentation by Product
The Global Aortic Aneurysm Market has been segmented by Product into Stent Grafts, Catheters and Others.
The global aortic aneurysm market is segmented by product into several categories, with prominent segments including stent grafts, catheters, and other medical devices. Stent grafts are a key component in the management of aortic aneurysms, offering a minimally invasive alternative to traditional open surgery. These devices are designed to reinforce weakened sections of the aorta and redirect blood flow, reducing the risk of aneurysm rupture. Stent grafts come in various designs and materials, tailored to fit different anatomical configurations and patient needs.
Catheters are another essential category within the market, primarily used for diagnostic purposes and in minimally invasive procedures such as endovascular repair (EVAR). These thin, flexible tubes allow healthcare providers to access and navigate through blood vessels under imaging guidance, facilitating the delivery of stent grafts or other therapeutic interventions directly to the site of the aneurysm. Advances in catheter technology continue to enhance precision and safety during procedures, contributing to improved patient outcomes and recovery times.
The category of others encompasses a range of additional products and technologies integral to the comprehensive management of aortic aneurysms. This includes imaging equipment such as ultrasound, CT scanners, and MRI machines used for diagnosis and monitoring. It also includes ancillary devices like guidewires, sheaths, and sealing systems that support procedural success and patient safety. The diversity within this segment reflects ongoing innovation and investment in expanding the armamentarium of tools available to healthcare providers, ultimately aiming to optimize treatment outcomes for individuals affected by aortic aneurysms globally.
Global Aortic Aneurysm Market, Segmentation by Treatment
The Global Aortic Aneurysm Market has been segmented by Treatment into Endovascular Aneurysm Repair (EVAR) and Open Surgical Repair (OSR).
The global aortic aneurysm market is segmented by treatment methods, primarily categorized into endovascular aneurysm repair (EVAR) and open surgical repair (OSR). Endovascular aneurysm repair involves a minimally invasive approach where a stent graft is inserted into the aorta through small incisions in the groin or other access points. This technique is favored for its reduced recovery times, lower morbidity rates, and shorter hospital stays compared to traditional open surgical repair.
On the other hand, open surgical repair remains a viable treatment option, particularly for complex or anatomically challenging cases of aortic aneurysms. This approach involves a large incision in the abdomen or chest to directly visualize and replace the weakened portion of the aorta with a synthetic graft. While more invasive, open surgical repair may be necessary in cases where endovascular techniques are not feasible or carry higher risks, such as in patients with severe anatomical constraints or extensive disease involvement.
The choice between EVAR and OSR depends on various factors, including the size and location of the aneurysm, patient anatomy, overall health status, and surgeon expertise. Advances in endovascular technologies and techniques have expanded the applicability of EVAR, making it the preferred treatment for many patients due to its minimally invasive nature and favorable outcomes. However, ongoing research and innovation in both EVAR and OSR continue to refine treatment strategies and improve long-term patient outcomes in the global management of aortic aneurysms.
Global Aortic Aneurysm Market, Segmentation by End User
The Global Aortic Aneurysm Market has been segmented by End User into Hospitals And Clinics, Ambulatory Surgery Centers (ASCs) and Others.
The global aortic aneurysm market is segmented by end users into hospitals and clinics, ambulatory surgery centers (ASCs), and other healthcare facilities. Hospitals and clinics represent the largest segment, serving as the primary venues for the diagnosis, treatment, and management of aortic aneurysms. These institutions provide comprehensive care, ranging from initial diagnosis using advanced imaging technologies to both surgical and non-surgical interventions such as endovascular repairs and follow-up monitoring.
Ambulatory surgery centers (ASCs) have emerged as an increasingly popular choice for certain procedures related to aortic aneurysms, particularly those that can be performed on an outpatient basis or with shorter hospital stays. ASCs offer specialized facilities equipped with advanced surgical equipment and skilled medical staff, providing a convenient and cost-effective option for patients requiring minimally invasive procedures like endovascular repairs. This segment continues to grow as healthcare systems emphasize outpatient care and efficiency in treatment delivery.
The category of others encompasses various healthcare facilities beyond hospitals, clinics, and ASCs that play roles in the global aortic aneurysm market. These may include academic medical centers, research institutions conducting clinical trials, and specialized treatment centers focusing on cardiovascular diseases. Each of these facilities contributes uniquely to the continuum of care for patients with aortic aneurysms, supporting efforts in research, education, and specialized treatment modalities aimed at improving patient outcomes and advancing medical knowledge in the field.
Global Aortic Aneurysm Market, Segmentation by Geography
In this report, the Global Aortic Aneurysm Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Aortic Aneurysm Market Share (%), by Geographical Region, 2024
The global aortic aneurysm market is segmented geographically into several regions, each with its unique dynamics and healthcare landscape influencing market trends. North America holds a significant share of the market, driven by high healthcare expenditures, advanced healthcare infrastructure, and a growing prevalence of aortic aneurysms among the aging population. The region benefits from robust research and development activities, leading to continuous advancements in diagnostic technologies and treatment options such as endovascular repair techniques.
Europe is another key region in the global aortic aneurysm market, characterized by a well-established healthcare system and increasing adoption of minimally invasive procedures. Countries like the UK, Germany, and France are at the forefront of technological innovation in medical devices, including stent grafts and imaging modalities, contributing to improved patient outcomes and quality of care. The region also sees significant investments in healthcare research aimed at enhancing understanding and management of aortic aneurysms.
Asia Pacific is witnessing rapid growth in the aortic aneurysm market, driven by expanding healthcare infrastructure, rising healthcare expenditures, and increasing awareness about cardiovascular diseases. Countries such as China, Japan, and India are experiencing a demographic shift towards an aging population, leading to a higher prevalence of aortic aneurysms and driving demand for advanced diagnostic and treatment solutions. The region's market growth is further supported by collaborations between international medical device companies and local healthcare providers to address regional healthcare needs effectively.
Overall, the geographic segmentation of the global aortic aneurysm market highlights diverse regional dynamics influenced by demographic trends, healthcare policies, technological advancements, and healthcare expenditure patterns. These factors collectively shape the market landscape and opportunities for stakeholders in addressing the challenges posed by aortic aneurysms on a global scale.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Aortic Aneurysm Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population
- Technological Advancements
- Increasing Awareness
-
Rising Healthcare Expenditure: Rising healthcare expenditure is a significant driver influencing the global aortic aneurysm market. As economies grow and populations age, there is an increasing allocation of resources towards healthcare, including diagnostics, treatments, and research related to aortic aneurysms. This trend is particularly pronounced in developed regions where healthcare infrastructure is robust and funding for innovative medical technologies is readily available.
The rising prevalence of aortic aneurysms, coupled with advancements in medical science and technology, necessitates higher healthcare spending. Investment in early detection technologies such as advanced imaging modalities and genetic screening contributes to early intervention, potentially reducing long-term healthcare costs associated with complications like aneurysm rupture. As healthcare systems worldwide strive to enhance patient outcomes and reduce morbidity and mortality rates, the increase in healthcare expenditure underscores a commitment to addressing the challenges posed by aortic aneurysms comprehensively.
Restraints
- High Treatment Costs
- Lack of Skilled Surgeons
- Stringent Regulatory Framework
-
Limited Access to Healthcare: Limited access to healthcare poses a significant restraint in the global management of aortic aneurysms. This issue is particularly acute in underserved regions and among socioeconomically disadvantaged populations, where barriers such as geographic remoteness, inadequate infrastructure, and financial constraints hinder timely access to essential healthcare services. As a result, individuals in these areas may face delays in diagnosis, treatment, and follow-up care for aortic aneurysms, potentially exacerbating health outcomes and increasing the burden of disease.
The consequences of limited access to healthcare are profound, as delayed diagnosis and treatment of aortic aneurysms can lead to higher rates of complications, including aneurysm rupture, which carries a substantial risk of mortality. Efforts to mitigate these disparities include initiatives aimed at improving healthcare infrastructure, expanding access to diagnostic tools and specialist care, and implementing public health programs to raise awareness about the importance of early detection and intervention. Addressing these challenges is crucial to ensuring equitable access to effective treatments and improving outcomes for all individuals affected by aortic aneurysms globally.
Opportunities
- Emerging Markets Expansion
- Development of Minimally Invasive Techniques
- Personalized Medicine Approaches
-
Collaborative Research Initiatives: Collaborative research initiatives play a pivotal role in advancing the understanding and treatment of aortic aneurysms on a global scale. These initiatives typically involve partnerships between healthcare providers, academic institutions, pharmaceutical companies, and research organizations. By pooling expertise, resources, and data, collaborative efforts accelerate the pace of innovation in diagnostics, treatment modalities, and patient care strategies.
Through collaborative research, multidisciplinary teams can explore novel approaches to managing aortic aneurysms, including the development of innovative biomaterials for stent grafts, refinement of imaging technologies for more accurate diagnosis, and exploration of personalized medicine approaches tailored to individual patient needs. Such initiatives foster a synergistic exchange of knowledge and ideas, promoting the translation of scientific discoveries into clinical practice.
Competitive Landscape Analysis
Key players in Global Aortic Aneurysm Market include
- Medtronic Plc
- Cook Medical
- Terumo Medical Corporation
- Microport Scientific Corporation
- MAQUET Holding B.V. & Co. KG
- Endologix, Inc.
- W. L. Gore & Associates
- Lombard Medical Limited
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Product
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Aortic Aneurysm Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population
- Technological Advancements
- Increasing Awareness
- Rising Healthcare Expenditure
- Restraints
- High Treatment Costs
- Lack of Skilled Surgeons
- Stringent Regulatory Framework
- Limited Access to Healthcare
- Opportunities
- Emerging Markets Expansion
- Development of Minimally Invasive Techniques
- Personalized Medicine Approaches
- Collaborative Research Initiatives
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competiitve Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Aortic Aneurysm Market, By Type, 2021 - 2031 (USD Million)
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Global Aortic Aneurysm Market, By Product, 2021 - 2031 (USD Million)
- Stent Grafts
- Catheters
- Others
- Global Aortic Aneurysm Market, By Treatment, 2021 - 2031 (USD Million)
- Endovascular Aneurysm Repair (EVAR)
- Open Surgical Repair (OSR)
- Global Aortic Aneurysm Market, By End User, 2021 - 2031 (USD Million)
- Hospitals & Clinics
- Ambulatory Surgery Centers (ASCs)
- Others
- Global Aortic Aneurysm Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Aortic Aneurysm Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Medtronic Plc
- Cook Medical
- Terumo Medical Corporation
- Microport Scientific Corporation
- MAQUET Holding B.V. & Co. KG
- Endologix, Inc.
- W. L. Gore & Associates
- Lombard Medical Limited
- Company Profiles
- Analyst Views
- Future Outlook of the Market